We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
TEVA V. SANDOZ: THE SUPREME COURT REJECTS MILLENNIAL FEDERAL CIRCUIT'S "CLEARLY ERRONEOUS" REVIEW STANDARD.
- Authors
Havens, Cassandra E.
- Abstract
The article focuses on the decision of the U.S. Supreme Court in the case Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. which established a new hybrid standard of review for patent claim construction decisions. It mentions that patent claim construction should be reviewed for clear error pursuant to Federal Rule of Civil Procedure 52. It also mentions that the U.S. Supreme Court in the case Markman v. Westview Instruments, Inc. on patent infringement.
- Subjects
TEVA Pharmaceuticals USA Inc. v. Sandoz (Supreme Court case); STANDARD of review (Law); PATENT claim interpretation; UNITED States. Supreme Court. Federal rules of civil procedure; MARKMAN v. Westview Instruments Inc. (Supreme Court case); PATENT suits
- Publication
Berkeley Technology Law Journal, 2016, Vol 31, p399
- ISSN
1086-3818
- Publication type
Article
- DOI
10.15779/Z384R9G